Search

Search results

  1. Case for Mutual Recognition of Drug Approvals

    This study aims to measure the difference in access to new medicines that results from duplication of effort in Canada. By compiling a list of new drugs approved in Canada between 2005-2011/12 (Health Canada moved from calendar-year to fiscal-year ...

  2. Bulk prescription drug purchasing: It's not all savings

    Appeared in the National Post As part of their struggle with budget realities and the growing cost of health care, Canada's provinces continue to work on bulk purchasing agreements for pharmaceuticals as a way to save money. Unfortunately, the recent ...

  3. Trade and Economic Benefits of Enhanced Intellectual Property Protection for Pharmaceuticals in Canada

    Canada is in the midst of negotiations over the Comprehensive Economic and Trade Agreement (CETA) with the European Union, and the multi-country Trans-Pacific Partnership (TPP). A key issue to be settled in these negotiations is intellectual property (IP) ...

  4. Cutting Canada's Drug Lag while Improving Safety

    Appeared in the Guelph Mercury New medicines are a central component of modern medical care, treating illness effectively, providing more comfortable treatment regimes, extending life and reducing disability, and sometimes offering new treatment options ...